Gfs Advisors Raised Cvs Health (CVS) Position; 2U (TWOU) SI Decreased By 5.55%

February 24, 2018 - By Stephen Andrade

2U Inc (NASDAQ:TWOU) had a decrease of 5.55% in short interest. TWOU’s SI was 6.47 million shares in February as released by FINRA. Its down 5.55% from 6.85 million shares previously. With 344,200 avg volume, 19 days are for 2U Inc (NASDAQ:TWOU)’s short sellers to cover TWOU’s short positions. The stock increased 1.36% or $1.06 during the last trading session, reaching $79.1. About 289,111 shares traded. 2U, Inc. (NASDAQ:TWOU) has risen 55.92% since February 24, 2017 and is uptrending. It has outperformed by 39.22% the S&P500.

Gfs Advisors Llc increased Cvs Health Corp (CVS) stake by 6.88% reported in 2017Q3 SEC filing. Gfs Advisors Llc acquired 5,930 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Gfs Advisors Llc holds 92,072 shares with $7.49 million value, up from 86,142 last quarter. Cvs Health Corp now has $69.15 billion valuation. The stock increased 0.24% or $0.16 during the last trading session, reaching $68.16. About 5.80M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 24, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.




2U, Inc. provides cloud-based software-as-a-service solutions for nonprofit colleges and universities to deliver education to students. The company has market cap of $4.13 billion. The Company’s cloud SaaS platform solutions include online campus, an online learning platform that enables its clients to offer educational content together with instructor-led classes in a live, intimate, and engaging setting through proprietary Web and mobile applications. It currently has negative earnings. The companyÂ’s integrated back-end applications launch, operate, and support clients' programs, as well as provide clients with real-time data and analytical insight related to student performance and engagement, student satisfaction, and enrollment.

Among 13 analysts covering 2U (NASDAQ:TWOU), 13 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. 2U had 38 analyst reports since August 7, 2015 according to SRatingsIntel. Compass Point maintained the stock with “Buy” rating in Friday, August 7 report. On Friday, October 16 the stock rating was upgraded by Goldman Sachs to “Buy”. The stock has “Buy” rating by Robert W. Baird on Monday, January 8. Needham maintained the shares of TWOU in report on Friday, February 26 with “Buy” rating. The rating was maintained by Needham with “Buy” on Friday, August 7. The firm has “Outperform” rating by Barrington Research given on Friday, August 5. Robert W. Baird maintained it with “Buy” rating and $66.0 target in Friday, October 6 report. Robert W. Baird maintained the stock with “Outperform” rating in Tuesday, August 8 report. The rating was maintained by Barrington with “Buy” on Wednesday, November 8. The stock of 2U, Inc. (NASDAQ:TWOU) earned “Overweight” rating by KeyBanc Capital Markets on Tuesday, January 30.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 72 analyst reports since July 22, 2015 according to SRatingsIntel. As per Wednesday, August 5, the company rating was maintained by RBC Capital Markets. The rating was maintained by S&P Research on Monday, November 2 with “Strong Buy”. The stock of CVS Health Corporation (NYSE:CVS) has “Neutral” rating given on Monday, February 6 by Atlantic Securities. The stock has “Hold” rating by Jefferies on Friday, June 9. The stock of CVS Health Corporation (NYSE:CVS) has “Outperform” rating given on Monday, November 2 by Oppenheimer. The firm has “Buy” rating by Mizuho given on Wednesday, November 9. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Monday, December 12 by Jefferies. Raymond James upgraded the shares of CVS in report on Thursday, January 4 to “Buy” rating. The rating was reinitiated by Evercore on Wednesday, August 19 with “Buy”. The firm has “Hold” rating given on Wednesday, August 16 by Wolfe Research.

Since September 11, 2017, it had 0 insider purchases, and 6 insider sales for $39.50 million activity. Foulkes Helena had sold 39,340 shares worth $3.22 million. Moriarty Thomas M had sold 20,547 shares worth $1.67 million on Monday, October 2. Roberts Jonathan C also sold $7.13M worth of CVS Health Corporation (NYSE:CVS) shares. The insider Denton David M sold 237,078 shares worth $18.88 million.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: